Oxyphenisatine

CHEMBL245807 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

317.3 g/mol

LogP

3.2

Phase

4

A stimulant laxative closely related to oxyphenisatin acetate, sharing the same mechanism and the same withdrawal history due to hepatotoxicity. It was used for constipation but discontinued due to liver injury risks.

Peso Molecular

317,3000 g/mol

LogP

3,20

TPSA

69,60 Å²

Regra dos 5 de Lipinski

Aprovado

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

O=C1Nc2ccccc2C1(c1ccc(O)cc1)c1ccc(O)cc1

InChI

InChI=1S/C20H15NO3/c22-15-9-5-13(6-10-15)20(14-7-11-16(23)12-8-14)17-3-1-2-4-18(17)21-19(20)24/h1-12,22-23H,(H,21,24)

Molecular Formula

C20H15NO3

HBD / HBA

3 / 3

Ligações Rotacionáveis

2

Átomos Pesados

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

A stimulant laxative closely related to oxyphenisatin acetate, sharing the same mechanism and the same withdrawal history due to hepatotoxicity. It was used for constipation but discontinued due to liver injury risks.

Yes, Oxyphenisatine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL245807. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 31315. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Procura informações acessíveis para o paciente?

Oxyphenisatine no PillFYI

Estrutura

Dados Rápidos

Fórmula: C20H15NO3

Links Externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.